{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:56:08Z","timestamp":1768434968385,"version":"3.49.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":68,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and importance<\/jats:title>\n                    <jats:p>Aggressive angiomyxoma is characterized as a non-capsulated soft mass with the ability to progress to surrounding tissues but without metastasis to distant tissues. Slowing tumor extension leading delayed tumor diagnosis, expression of different types of hormonal receptors, therapeutic ineffectiveness of noninvasive treatment approaches and misdiagnosis have remained as the major challenges for managing this tumor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Herein, we described a case of aggressive angiomyxoma located in the posterior of the uterus and vagina that as successfully managed surgically to remove tumor mass followed by gonadotropin-releasing hormone (GnRH) agonist to prevent tumor recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion<\/jats:title>\n                    <jats:p>Surgical resection is the treatment of choice in aggressive angiomyxoma with complete success rate, however despite such successfulness, about two-thirds of patients experienced postoperative recurrence rate that could be prevented by hormone-based therapy especially GnRH agonist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Aggressive angiomyxoma is a rare tumor with locally invasive behavior. As misdiagnosis is common imaging like MRI with DWI should be considered. The best treatment is surgical resection by experienced surgeons in tertiary referral hospitals. Even with complete resection, the recurrence rate is high. So adjuvant medical treatment seems to be necessary.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2021.105756","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T05:21:51Z","timestamp":1615699311000},"page":"105756","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Aggressive angiomyxoma of the pelvis surgical management in a case with delayed diagnosis"],"prefix":"10.1097","volume":"81","author":[{"given":"Setareh","family":"Akhavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh","family":"Nikfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Behboudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahrooz","family":"Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Saffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-56-20260114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.NPR.0000490398.27464.0b","article-title":"Aggressive angiomyxoma","volume":"41","author":"Chong","year":"2016","journal-title":"Nurse Pract"},{"key":"R2-56-20260114","first-page":"288","article-title":"Aggressive pelvic angiomyxoma","volume":"67","author":"Espiritusanto","year":"2014","journal-title":"Arch. Esp. Urol"},{"key":"R3-56-20260114","first-page":"1098","article-title":"Clinicopathological analysis of aggressive angiomyxoma of soft tissue in abdomino-pelvic cavity","volume":"50","author":"Liu","year":"2018","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"R4-56-20260114","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg"},{"key":"R5-56-20260114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1600-0412.2000.079003216.x","article-title":"Aggressive angiomyxoma in females: is radical resection the only option?","volume":"79","author":"Chan","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand"},{"key":"R6-56-20260114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5334\/jbsr.2230","article-title":"Pelvic soft tissue aggressive angiomyxoma","volume":"104","author":"Amante","year":"2020","journal-title":"J. Belg. Soc. Radiol"},{"key":"R7-56-20260114","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.urology.2020.05.028","article-title":"Aggressive angiomyxoma in an 11-year-old boy - diagnostic and therapeutic dilemmas: an unusual case report and review of the literature","volume":"144","author":"Korecka","year":"2020","journal-title":"Urology"},{"key":"R8-56-20260114","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00404-020-05592-5","article-title":"Retrospective analysis of clinicopathological features and prognosis for aggressive angiomyxoma of 27 cases in a tertiary center: a 14-year survey and related literature review","volume":"302","author":"Zou","year":"2020","journal-title":"Arch. Gynecol. Obstet"},{"key":"R9-56-20260114","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2214\/AJR.13.11668","article-title":"Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation","volume":"202","author":"Surabhi","year":"2014","journal-title":"AJR Am. J. Roentgenol"},{"key":"R10-56-20260114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<79::AID-CNCR13>3.0.CO;2-4","article-title":"Aggressive angiomyxoma: a clinicopathologic study of 29 female patients","volume":"78","author":"Fetsch","year":"1996","journal-title":"Cancer"},{"key":"R11-56-20260114","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3892\/etm.2016.3097","article-title":"Local recurrent vaginal aggressive angiomyxoma misdiagnosed as cellular angiomyofibroblastoma: a case report","volume":"11","author":"Wang","year":"2016","journal-title":"Exp. Ther. Med"},{"key":"R12-56-20260114","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1634\/theoncologist.2018-0338","article-title":"Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study","volume":"24","author":"Fuc\u00e0","year":"2019","journal-title":"Oncologist"},{"key":"R13-56-20260114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2019.08.007","article-title":"Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis","volume":"143","author":"Pannier","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"R14-56-20260114","doi-asserted-by":"crossref","first-page":"20200255","DOI":"10.1259\/bjr.20200255","article-title":"Aggressive pelvic angiomyxoma and its mimics: can imaging be the guiding light?","volume":"93","author":"Kumar","year":"2020","journal-title":"Br. J. Radiol"},{"key":"R15-56-20260114","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejso.2009.11.006","article-title":"Aggressive angiomyxoma: a case series and literature review","volume":"36","author":"Haldar","year":"2010","journal-title":"Eur. J. Surg. Oncol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261221002571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261221002571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2021.105756","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:26:05Z","timestamp":1768397165000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2021.105756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2021.105756","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}